Global Sustainable Development

Leave a reply

February 12, 2015 Aileron Therapeutics commences Phase I study using a stapled peptide to target p53 and intracellular protein-protein interaction in cancer patients.

February 10, 2015 Hospira, Inc. and Pfenex Inc. announce partnership to develop and market "wet" age-related macular degeneration medication.

February 9, 2015 New insulin analogues containing phenyl boronic acids for glucose-sensing contributed from Bob Langer and the groups at MIT.